WallStreetZenWallStreetZen

NASDAQ: SURG
Surgepays Inc Stock

$4.18-0.04 (-0.95%)
Updated May 20, 2024
SURG Price
$4.18
Fair Value Price
N/A
Market Cap
$81.14M
52 Week Low
$3.28
52 Week High
$9.23
P/E
3.48x
P/B
1.45x
P/S
0.51x
PEG
0.02x
Dividend Yield
N/A
Revenue
$133.79M
Earnings
$17.30M
Gross Margin
27%
Operating Margin
11.95%
Profit Margin
12.9%
Debt to Equity
0.24
Operating Cash Flow
$11M
Beta
0.73
Next Earnings
N/A
Ex-Dividend
N/A
Next Dividend
N/A

SURG Overview

SurgePays, Inc., a financial technology and telecommunications company, provides services to the underbanked community in the United States. Its blockchain platform utilizes a suite of financial and prepaid products to convert corner stores and bodegas into tech-hubs for underbanked neighborhoods. The company offers voice and SMS text messaging services to subsidized and direct retail prepaid customers, as well as to low-income consumers. It also offers subsidized mobile broadband services to consumers in California, Colorado, Florida, Illinois, Maryland, Mississippi, Missouri, Nevada, New Jersey, Ohio, Oklahoma, Rhode Island, Tennessee, and Texas, as well as prepaid wireless plans. In addition, the company provides marketing business intelligence, plaintiff generation, and case load management solutions primarily to law firms in the mass tort industry. Further, it operates a bilingual operations center offering the Company with sales support, customer service, IT infrastructure design, graphic media, database programming, software development, revenue assurance, lead generation, and other various operational support services. The company is headquartered in Bartlett, Tennessee.

Zen Score

Industry Average (27)
You've viewed Zen Score for 10/10 free stocks. Upgrade to Premium to see how SURG scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.

Due Diligence Checks

SURG ($4.18) is trading below its intrinsic value of $75.27, according to an updated version of Benjamin Graham's Formula from Chapter 11 of "The Intelligent Investor"
Below Benjamin Graham Formula Value Valuation
SURG is good value based on its earnings relative to its share price (3.48x), compared to the US market average (31.12x)
P/E vs Market Valuation
SURG is good value based... subscribe to Premium to read more.
P/E vs Industry Valuation
There are 30 more SURG due diligence checks available for Premium users.

Be the first to know about important SURG news, forecast changes, insider trades & much more!

SURG News

Valuation

SURG price to earnings (PE)

For valuing profitable companies with steady earnings
Company
3.48x
Industry
32.21x
Market
31.12x
SURG is good value based... subscribe to Premium to read more.
P/E vs Industry Valuation
SURG is good value based... subscribe to Premium to read more.
P/E vs Market Valuation

SURG price to book (PB)

For valuing companies that are loss-making or have lots of physical asset
Company
1.45x
Industry
6.61x
SURG is good value based... subscribe to Premium to read more.
P/B vs Industry Valuation

SURG price to earnings growth (PEG)

For valuing profitable companies with growth potential
SURG is good value based... subscribe to Premium to read more.
PEG Value Valuation

SURG's financial health

Profit margin

Revenue
$31.4M
Net Income
$1.2M
Profit Margin
3.9%
SURG's Earnings (EBIT) of $15.99M... subscribe to Premium to read more.
Interest Coverage Financials
SURG's profit margin has increased... subscribe to Premium to read more.
Profit Margin Growth Financials

Assets to liabilities

Assets
$69.6M
Liabilities
$13.4M
Debt to equity
0.24
SURG's short-term assets ($59.06M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
SURG's short-term assets ($59.06M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
SURG's debt relative to shareholder... subscribe to Premium to read more.
Shrinking Debt Financials
SURG's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials

Cash flow

Operating
$4.0M
Investing
$0.0
Financing
$24.3M
SURG's operating cash flow ($11.46M)... subscribe to Premium to read more.
Debt Coverage Financials

SURG vs App Stocks

TickerMarket Cap1d %P/EP/B
SURG$81.14M-0.83%3.48x1.45x
AIXI$78.53M0.00%-2.92x-16.15x
DPSI$77.27M+0.20%100.60x4.07x
UPLD$76.98M+0.36%-0.58x3.83x
SSNT$86.06M+5.13%-73.59x11.31x

Surgepays Stock FAQ

What is Surgepays's quote symbol?

(NASDAQ: SURG) Surgepays trades on the NASDAQ under the ticker symbol SURG. Surgepays stock quotes can also be displayed as NASDAQ: SURG.

If you're new to stock investing, here's how to buy Surgepays stock.

What is the 52 week high and low for Surgepays (NASDAQ: SURG)?

(NASDAQ: SURG) Surgepays's 52-week high was $9.23, and its 52-week low was $3.28. It is currently -54.71% from its 52-week high and 27.44% from its 52-week low.

How much is Surgepays stock worth today?

(NASDAQ: SURG) Surgepays currently has 19,411,549 outstanding shares. With Surgepays stock trading at $4.18 per share, the total value of Surgepays stock (market capitalization) is $81.14M.

Surgepays stock was originally listed at a price of $59.50 in Jan 17, 2018. If you had invested in Surgepays stock at $59.50, your return over the last 6 years would have been -92.97%, for an annualized return of -35.76% (not including any dividends or dividend reinvestments).

How much is Surgepays's stock price per share?

(NASDAQ: SURG) Surgepays stock price per share is $4.18 today (as of May 20, 2024).

What is Surgepays's Market Cap?

(NASDAQ: SURG) Surgepays's market cap is $81.14M, as of May 22, 2024.

Market cap (market capitalization) is the total market value of a publicly traded company's outstanding shares.

Surgepays's market cap is calculated by multiplying SURG's current stock price of $4.18 by SURG's total outstanding shares of 19,411,549.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.